Inter
NASDAQ: ICPT
172.13
+ 6.11 (3.68%)
4:00 PM ET on Sep 27, 2016
Delayed at least 20 minutes.

Recent Press Releases

Sep 19, 2016
Intercept Pharmaceuticals Files New Drug Submission to Health Canada for Marketing Approval of Obeticholic Acid for the Treatment of Patients with Primary Biliary Cholangitis
Sep 2, 2016
Intercept to Present at Upcoming Investor Conferences
View all press releases >

Recent Events & Presentations

Sep 13, 2016 at 1:30 PM
Morgan Stanley Global Healthcare Conference
Sep 8, 2016 at 2:35 PM
Baird's 2016 Healthcare Conference
Aug 16, 2016 at 3:40 PM ET
2016 Wedbush PacGrow Healthcare Conference
Aug 4, 2016 at 8:30 AM ET
Second Quarter 2016 Financial Results and Conference Call
Jun 8, 2016 at 4:00 PM PT
Goldman Sachs 37th Annual Global Healthcare Conference
Jun 7, 2016 at 3:30 PM ET
Jefferies 2016 Healthcare Conference
May 31, 2016 at 8:30 AM ET
Intercept Pharmaceuticals, Inc. Conference Call
May 22, 2016
Intercept welcomes you to Booth #4253 at Digestive Disease Week®
May 5, 2016 at 5:00 PM ET
First Quarter 2016 Financial Results and Conference Call
Apr 7, 2016 at 5:30 PM ET
Intercept Pharmaceuticals, Inc. Conference Call
Dec 1, 2015 at 9:00 AM ET
Intercept Pharmaceuticals 2015 Analyst/Investor Event
View all events & presentations >
Corporate Governance >
Financial Information >
Stock Information >
Investor FAQs >
Contact Us >

450 W 15th Street, Suite 505 | New York, NY 10011 | T: 844-782-ICPT | F: 646-747-1001
© 2016 Intercept Pharmaceuticals, Inc.